Bioactivity:

CBR-2092 is a DNA-directed RNA polymerase and DNA topoisomerase inhibitor. CBR-2092 exhibited rifampin-like potency as an inhibitor of RNA polymerase, was an equipotent (balanced) inhibitor of DNA gyrase and DNA topoisomerase IV, and retained activity aga

CAS nr:

922717-97-3

Purity:

98%

Molecular Weight:

1205,39

SMILES:

CC1=C(O[C@@]2(C)C3=O)C3=C(C(O)=C(/C=N/N4CCC(N(C)C5([C@@H]6CCN(C7=C(C)C(N8C=C7F)=C(C9CC9)C=C(C(O)=O)C8=O)C6)CC5)CC4)C(NC(/C(C)=C\C=C\[C@H](C)[C@@H]([C@@H](C)[C@@H](O)[C@H]([C@@H]([C@H](C)[C@@H](OC)/C=C/O2)OC(C)=O)C)O)=O)=C%10O)C%10=C1O

Formula:

C65H81FN6O15

Pathway:

Target: